Dermata Therapeutics, Inc. (DRMA)
NASDAQ·Healthcare·Biotechnology
$1.09
+1.40%
Mkt Cap $903.06K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+450.5%
Consensus $6.00 vs current $1.09
NASDAQ·Healthcare·Biotechnology
$1.09
+1.40%
Mkt Cap $903.06K
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
+450.5%
Consensus $6.00 vs current $1.09